2025 saw a 30% drop in EBITDA due to overcapacity and weak demand, but free cash flow improved 57%. 2026 guidance projects $450–$500 million EBITDA, with deleveraging and asset sales as top priorities. Market recovery remains uncertain, but strategic growth and cost controls are in focus.
Based on
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.